The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Abstract
Purpose: To provide evidence-based recommendations to oncologists and others on potentially curative therapy for patients with localized pancreatic cancer. Methods: ASCO convened a panel of medical oncology, radiation oncology, surgical oncology, palliative care, and advocacy experts and conducted a systematic review of literature from January 2002 to June 2015. Outcomes included overall survival, disease-free survival, progression-free survival, and adverse events. Results: Nine randomized controlled trials met the systematic review criteria. Recommendations: A multiphase computed tomography scan of the abdomen and pelvis or magnetic resonance imaging should be performed for all patients to assess the anatomic relationships of the primary tumor and for the presence of intra-abdominal metastases. Baseline performance status, comorbidity profile, and goals of care should be evaluated and established. Primary surgical resection is recommended for all patients who have no metastases, appropriate performance and comorbidity profiles, and no radiographic interface between primary tumor and mesenteric vasculature. Preoperative therapy is recommended for patients who meet specific characteristics. All patients with resected pancreatic cancer who did not receive preoperative therapy should be offered 6 months of adjuvant chemotherapy in the absence of contraindications. Adjuvant chemoradiation may be offered to patients who did not receive preoperative therapy with microscopically positive margins (R1) after resection and/or who had node-positive disease after completion of 4 to 6 months of systemic adjuvant chemotherapy. Patients should have a full assessment of symptoms, psychological status, and social supports and should receive palliative care early. Patients who have completed treatment and have no evidence of disease should be monitored. Additional information is available at www.asco.org/guidelines/PCPC and www.asco.org/guidelineswiki .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
Neoptolemos, J. P., Stocken, D. D., Friess, H., Bassi, C., Dunn, J. A., Hickey, H., Beger, H., Fernandez-Cruz, L., Dervenis, C., Lacaine, F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032295 · Cited by 2,716
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J., Ridwelski, K., Schramm, H., Fahlke, J., Zuelke, C., Burkart, C., et al. (2007) · JAMA · doi:10.1001/jama.297.3.267 · Cited by 2,419
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study
Hurria, A., Togawa, K., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Lichtman, S. M., Gajra, A., Bhatia, S., Katheria, V., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7625 · Cited by 1,841 · cited 1×
“Measurement of constructs such as frailty and performance status is important, and such measurements may be used to predict chemotherapy toxicity and surgical risk.(26,27) Geriatric assessment can identify underlying issues that increase the risk of adverse outcomes of older patients undergoing major abdominal surgery.”
BackgroundSelf-citationOettle, H., Neuhaus, P., Hochhaus, A., Hartmann, J. T., Gellert, K., Ridwelski, K., Niedergethmann, M., Zülke, C., Fahlke, J., Arning, M. B., et al. (2013) · JAMA · doi:10.1001/jama.2013.279201 · Cited by 1,794
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
KHORANA, A. A., FRANCIS, C. W., CULAKOVA, E., KUDERER, N. M., & LYMAN, G. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02374.x · Cited by 1,670
Self-citationEpstein, R. M., & Street, R. L. (2007) · PsycEXTRA Dataset · doi:10.1037/e481972008-001 · Cited by 1,590
Pancreatic Cancer: Adjuvant Combined Radiation and Chemotherapy Following Curative Resection
Kaiser, M. H. (1985) · Archives of Surgery · doi:10.1001/archsurg.1985.01390320023003 · Cited by 1,406
Lyman, G. H., Bohlke, K., Khorana, A. A., Kuderer, N. M., Lee, A. Y., Arcelus, J. I., Balaban, E. P., Clarke, J. M., Flowers, C. R., Francis, C. W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7351 · Cited by 1,371
Self-citationKlinkenbijl, J. H., Jeekel, J., Sahmoud, T., van Pel, R., Couvreur, M. L., Veenhof, C. H., Arnaud, J. P., Gonzalez, D. G., de Wit, L. T., Hennipman, A., et al. (1999) · Annals of Surgery · doi:10.1097/00000658-199912000-00006 · Cited by 1,286
Palliative Care for the Seriously Ill
Kelley, A. S., & Morrison, R. S. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1404684 · Cited by 804
Evans, D. B., Varadhachary, G. R., Crane, C. H., Sun, C. C., Lee, J. E., Pisters, P. W. T., Vauthey, J.-N., Wang, H., Cleary, K. R., Staerkel, G. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8634 · Cited by 731
Ballehaninna, U. K., & Chamberlain, R. S. (2012) · PubMed · doi:10.3978/j.issn.2078-6891.2011.021 · Cited by 701
Neoptolemos, J. P., Stocken, D. D., Dunn, J., Almond, J., Beger, H. G., Pederzoli, P., Bassi, C., Dervenis, C., Fernández‐Cruz, L., LACAINE, F., et al. (2001) · Annals of Surgery · doi:10.1097/00000658-200112000-00007 · Cited by 670
Ferrone, C. R., Finkelstein, D. M., Thayer, S. P., Muzikansky, A., Castillo, C. F.-D., & Warshaw, A. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3934 · Cited by 554
Al-Hawary, M. M., Francis, I. R., Chari, S. T., Fishman, E. K., Hough, D. M., Lu, D. S., Macari, M., Megibow, A. J., Miller, F. H., Mortele, K. J., et al. (2014) · Radiology · doi:10.1148/radiol.13131184 · Cited by 491
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
Katz, M. H. G., Wang, H., Fleming, J. B., Sun, C. C., Hwang, R. F., Wolff, R. A., Varadhachary, G., Abbruzzese, J. L., Crane, C. H., Krishnan, S., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0295-2 · Cited by 480
Self-citationVaradhachary, G. R., Wolff, R. A., Crane, C. H., Sun, C. C., Lee, J. E., Pisters, P. W. T., Vauthey, J.-N., Abdalla, E., Wang, H., Staerkel, G. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8642 · Cited by 466
Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer
Merkow, R. P., Bilimoria, K. Y., Tomlinson, J. S., Paruch, J. L., Fleming, J. B., Talamonti, M. S., Ko, C. Y., & Bentrem, D. J. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000378 · Cited by 458
Valle, J. W., Palmer, D., Jackson, R., Cox, T., Neoptolemos, J. P., Ghaneh, P., Rawcliffe, C. L., Bassi, C., Stocken, D. D., Cunningham, D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.7657 · Cited by 455
Ueno, H., Kosuge, T., Matsuyama, Y., Yamamoto, J., Nakao, A., Egawa, S., Doi, R., Monden, M., Hatori, T., Tanaka, M., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605256 · Cited by 439
Venous thromboembolism and prognosis in cancer
Khorana, A. A. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2009.12.023 · Cited by 410
Self-citationTissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic Cancer
Khorana, A. A., Ahrendt, S. A., Ryan, C. K., Francis, C. W., Hruban, R. H., Hu, Y. C., Hostetter, G., Harvey, J., & Taubman, M. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2351 · Cited by 394
Self-citationTumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
Duffy, M. J., Sturgeon, C., Lamerz, R., Haglund, C., Holubec, V. L., Klapdor, R., Nicolini, A., Topolcan, O., & Heinemann, V. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp332 · Cited by 381
Herman, J. M., Swartz, M. J., Hsu, C. C., Winter, J., Pawlik, T. M., Sugar, E., Robinson, R., Laheru, D. A., Jaffee, E., Hruban, R. H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8469 · Cited by 375
Self-citationWinter, J. M., Brennan, M. F., Tang, L. H., D’Angelica, M. I., DeMatteo, R. P., Fong, Y., Klimstra, D. S., Jarnagin, W. R., & Allen, P. J. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1900-3 · Cited by 340
Katz, M. H. G., Marsh, R., Herman, J. M., Shi, Q., Collison, E., Venook, A. P., Kindler, H. L., Alberts, S. R., Philip, P., Lowy, A. M., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2886-9 · Cited by 340
Self-citationOutcomes in Octogenarians Undergoing High-Risk Cancer Operation: A National Study
Finlayson, E., Fan, Z., & Birkmeyer, J. D. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.06.307 · Cited by 329
Smeenk, H. G., van Eijck, C. H. J., Hop, W. C., Erdmann, J., Tran, K. C. K., Debois, M., van Cutsem, E., van Dekken, H., Klinkenbijl, J. H., & Jeekel, J. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318156eef3 · Cited by 321
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
Maraveyas, A., Waters, J., Roy, R., Fyfe, D., Propper, D., Lofts, F., Sgouros, J., Gardiner, E., Wedgwood, K., Ettelaie, C., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.10.017 · Cited by 316
Regine, W. F., Winter, K. A., Abrams, R., Safran, H., Hoffman, J. P., Konski, A., Benson, A. B., Macdonald, J. S., Rich, T. A., & Willett, C. G. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1630-6 · Cited by 311
Morrison, R. S., Augustin, R., Souvanna, P., & Meier, D. E. (2011) · Journal of Palliative Medicine · doi:10.1089/jpm.2011.9634 · Cited by 291
Pawlik, T. M., Laheru, D., Hruban, R. H., Coleman, J., Wolfgang, C. L., Campbell, K., Ali, S., Fishman, E. K., Schulick, R. D., Herman, J. M., et al. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9929-7 · Cited by 273
Self-citationLiao, W.-C., Chien, K.-L., Lin, Y.-L., Wu, M.-S., Lin, J.-T., Wang, H.-P., & Tu, Y.-K. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70388-7 · Cited by 229
Wu, W., He, J., Cameron, J. L., Makary, M., Soares, K., Ahuja, N., Rezaee, N., Herman, J., Zheng, L., Laheru, D., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3722-6 · Cited by 229
(2008) · Cited by 225
Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer
Boone, B. A., Steve, J., Krasinskas, A. M., Zureikat, A. H., Lembersky, B. C., Gibson, M. K., Stoller, R. G., Zeh, H. J., & Bahary, N. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23392 · Cited by 193
Self-citationShiffman, R. N., Michel, G., Rosenfeld, R. M., & Davidson, C. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000172 · Cited by 184
Gleisner, A. L., Assumpcao, L., Cameron, J. L., Wolfgang, C. L., Choti, M. A., Herman, J. M., Schulick, R. D., & Pawlik, T. M. (2007) · Cancer · doi:10.1002/cncr.23074 · Cited by 183
Self-citationBoone, B. A., Steve, J., Zenati, M. S., Hogg, M. E., Singhi, A. D., Bartlett, D. L., Zureikat, A. H., Bahary, N., & Zeh, H. J. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3842-z · Cited by 182
Self-citationSwanson, R. S., Pezzi, C. M., Mallin, K., Loomis, A. M., & Winchester, D. P. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4036-4 · Cited by 182
Mayo, S. C., Gilson, M. M., Herman, J. M., Cameron, J. L., Nathan, H., Edil, B. H., Choti, M. A., Schulick, R. D., Wolfgang, C. L., & Pawlik, T. M. (2012) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2011.09.022 · Cited by 176
Self-citationPope, D., Ramesh, H., Gennari, R., Corsini, G., Maffezzini, M., Hoekstra, H. J., Mobarak, D., Sunouchi, K., Stotter, A., West, C., et al. (2006) · Surgical Oncology · doi:10.1016/j.suronc.2007.04.009 · Cited by 168
Schmidt, J., Abel, U., Debus, J., Harig, S., Hoffmann, K., Herrmann, T., Bartsch, D., Klein, J., Mansmann, U., Jäger, D., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2960 · Cited by 167
Dale, W., Hemmerich, J., Kamm, A., Posner, M. C., Matthews, J. B., Rothman, R., Palakodeti, A., & Roggin, K. K. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000226 · Cited by 158
Katz, M. H. G., Varadhachary, G. R., Fleming, J. B., et al. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0943-1 · Cited by 148
Self-citationO'Reilly, E. M., Perelshteyn, A., Jarnagin, W. R., Schattner, M. A., Gerdes, H., Capanu, M., Tang, L. H., LaValle, J., Winston, C. B., DeMatteo, R. P., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0000000000000251 · Cited by 138
The Use of Adjusted Preoperative CA 19-9 to Predict the Recurrence of Resectable Pancreatic Cancer
Kang, C. M., Kim, J. Y., Choi, G. H., Kim, K. S., Choi, J. S., Lee, W. J., & Kim, B. R. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2006.10.007 · Cited by 111
Racial and Ethnic Disparities in Care: The Perspectives of Cardiologists
Lurie, N., Fremont, A., Jain, A. K., Taylor, S. L., McLaughlin, R., Peterson, E., Kong, B. W., & Ferguson, T. B. (2005) · Circulation · doi:10.1161/01.cir.0000157738.12783.71 · Cited by 109
Maeda, A., Boku, N., Fukutomi, A., Kondo, S., Kinoshitá, T., Nagino, M., & Uesaka, K. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hym178 · Cited by 107
Heinrich, S., Pestalozzi, B. C., Lesurtel, M., Berrevoet, F. C., Laurent, S., Delpéro, J., Raoul, J., Bachellier, P., Dufour, P., Moehler, M. H., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-346 · Cited by 106
Managing malignant biliary obstruction in pancreas cancer: choosing the appropriate strategy.
Boulay, B. R., & Parepally, M. (2014) · PubMed Central · doi:10.3748/wjg.v20.i28.9345 · Cited by 101
Aggressive Surgery for Borderline Resectable Pancreatic Cancer
Yamada, S., Fujii, T., Sugimoto, H., Nomoto, S., Takeda, S., Kodera, Y., & Nakao, A. (2013) · Pancreas · doi:10.1097/mpa.0b013e31827b2d7c · Cited by 96
Tzeng, C.-W. D., Fleming, J. B., Lee, J. E., Wang, X., Pisters, P. W. T., Vauthey, J., Varadhachary, G., Wolff, R. A., & Katz, M. H. G. (2012) · HPB · doi:10.1111/j.1477-2574.2012.00445.x · Cited by 92
Self-citationDiagnosis of pancreatic tumors by endoscopic ultrasound-guided fine-needle aspiration
Ardengh, J. C., Lopes, C. V., de Lima, L. F. P., Oliveira, J. R., Venco, F. E., Santo, G. C., & Módena, J. L. P. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i22.3112 · Cited by 84
Core principles and values of effective team-based health care
Rowland, P. (2013) · Journal of Interprofessional Care · doi:10.3109/13561820.2013.820906 · Cited by 83
Pancreatic Cancer Clinical Trials and Accrual in the United States
Hoos, W. A., James, P. M., Rahib, L., Talley, A. W., Fleshman, J. M., & Matrisian, L. M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.4823 · Cited by 74
Trends in Racial Disparities in Pancreatic Cancer Surgery
Shah, A., Chao, K., Østbye, T., Castleberry, A. W., Pietrobon, R. S., Gloor, B., Clary, B. M., White, R. R., & Worni, M. (2013) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2304-4 · Cited by 70
Tzeng, C.-W. D., Abbott, D. E., Cantor, S. B., Fleming, J. B., Lee, J. E., Pisters, P. W. T., Varadhachary, G. R., Abbruzzese, J. L., Wolff, R. A., Ahmad, S. A., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2889-6 · Cited by 70
Self-citationAbbott, D. E., Tzeng, C.-W. D., Merkow, R. P., Cantor, S. B., Chang, G. J., Katz, M. H. G., Bentrem, D. J., Bilimoria, K. Y., Crane, C. H., Varadhachary, G. R., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2882-0 · Cited by 67
Self-citationNordby, T., Hugenschmidt, H., Fagerland, M. W., Ikdahl, T., Buanes, T. A., & Labori, K. J. (2013) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2013.02.020 · Cited by 56
Walters, D. M., LaPar, D. J., de Lange, E. E., Sarti, M., Stokes, J. B., Adams, R. B., & Bauer, T. W. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1693-4 · Cited by 55
Is It Worth Looking? Abdominal Imaging After Pancreatic Cancer Resection: a National Study
Witkowski, E. R., Smith, J. K., Ragulin-Coyne, E., Ng, S.-C., Shah, S. A., & Tseng, J. F. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1699-z · Cited by 53
Hallemeier, C. L., Botros, M. E., Corsini, M. M., Haddock, M. G., Gunderson, L. L., & Miller, R. C. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181f946fc · Cited by 47
Pancreatic Cancer in the USA: Persistence of Undertreatment and Poor Outcome
Enewold, L., Harlan, L. C., Tucker, T. C., & McKenzie, S. P. (2014) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-014-9668-x · Cited by 47
Davila, J. A., Chiao, E. Y., Hasche, J. C., Petersen, N. J., McGlynn, K. A., & Shaib, Y. H. (2008) · Pancreas · doi:10.1097/mpa.0b013e318187eb3f · Cited by 44
Lee, S., Reha, J. L., Tzeng, C.-W. D., Massarweh, N. N., Chang, G. J., Hetz, S. P., Fleming, J. B., Lee, J. E., & Katz, M. H. G. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3130-3 · Cited by 38
Self-citationMultidisciplinary Management of Pancreatic Cancer
Kumar, R., Herman, J. M., Wolfgang, C. L., & Zheng, L. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2012.12.003 · Cited by 34
Predicting early mortality in resectable pancreatic adenocarcinoma: A cohort study
Sohal, D. P. S., Shrotriya, S., Glass, K. T., Pelley, R. J., McNamara, M. J., Estfan, B. N., Shapiro, M. A., Wey, J. S., Chalikonda, S., Morris‐Stiff, G. J., et al. (2015) · Cancer · doi:10.1002/cncr.29298 · Cited by 33
Self-citationPappas, S. G., Christians, K. K., Tolat, P. P., Mautz, A. P., Lal, A., McElroy, L. M., Gamblin, T. C., Turaga, K. K., Tsai, S., Erickson, B. A., et al. (2013) · HPB · doi:10.1111/hpb.12074 · Cited by 31
Bao, P. Q., Potter, D. M., Eisenberg, D. P., Lenzner, D. E., Zeh, H. J., Lee, K. K. W., Hughes, S. J., Sanders, M. K., Young, J. L., & Moser, A. J. (2009) · HPB · doi:10.1111/j.1477-2574.2009.00110.x · Cited by 26
Self-citation
Cited by
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Conroy, T., Hammel, P., Hebbar, M., Ben Abdelghani, M., Wei, A. C., Raoul, J.-L., Choné, L., Francois, E., Artru, P., Biagi, J. J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809775 · Cited by 2,874
Ferrell, B. R., Temel, J. S., Temin, S., Alesi, E. R., Balboni, T. A., Basch, E. M., Firn, J. I., Paice, J. A., Peppercorn, J. M., Phillips, T., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.1474 · Cited by 2,117
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D., Froeling, F. E. M., Burkhart, R. A., Denroche, R. E., Jang, G.-H., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0349 · Cited by 1,092
Isaji, S., Mizuno, S., Windsor, J. A., Bassi, C., Fernández-del Castillo, C., Hackert, T., Hayasaki, A., Katz, M. H. G., Kim, S.-W., Kishiwada, M., et al. (2018) · Pancreatology · doi:10.1016/j.pan.2017.11.011 · Cited by 797
Self-citationACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts
Elta, G. H., Enestvedt, B. K., Sauer, B. G., & Lennon, A. M. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2018.14 · Cited by 719
Metadata
- Authors
- Khorana, A. A., Mangu, P. B., Berlin, J., Engebretson, A., Hong, T. S., Maitra, A., Mohile, S. G., Mumber, M., Schulick, R., Shapiro, M., Urba, S., Zeh, H. J., & Katz, M. H. G.
- Venue
- Journal of Clinical Oncology
- Published
- 2016-07-20
- Volume
- 34
- Issue
- 21
- Pages
- 2541-2556
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2416383077
- Cited by
- 366
- References
- 73
- FWCI
- 22.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.